Silence Therapeutics reported $-0.11 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.





Eps Change Date
AstraZeneca USD 2.58 0.46 Mar/2026
Autolus Therapeutics Ltd USD -0.27 0.07 Mar/2026
Hikma Pharmaceutical USD 0.65 0.12 Dec/2025
Novartis USD 1.99 0.04 Mar/2026
Roche Holding CHF 8.37 2.95 Dec/2025
Silence Therapeutics USD -0.11 0.03 Mar/2026